- Home
- TENX vs AQMS Comparison
TENX vs AQMS Comparison
Compare TENX & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- AQMS
- Stock Information
- Founded
- TENX 1967
- AQMS 2014
- Country
- TENX United States
- AQMS United States
- Employees
- TENX N/A
- AQMS N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- TENX Health Care
- AQMS Industrials
- Exchange
- TENX Nasdaq
- AQMS Nasdaq
- Market Cap
- TENX 21.8M
- AQMS 17.8M
- IPO Year
- TENX N/A
- AQMS 2015
- Fundamental
- Price
- TENX $6.37
- AQMS $1.98
- Analyst Decision
- TENX Strong Buy
- AQMS Strong Buy
- Analyst Count
- TENX 4
- AQMS 2
- Target Price
- TENX $20.67
- AQMS $30.00
- AVG Volume (30 Days)
- TENX 38.7K
- AQMS 371.2K
- Earning Date
- TENX 11-13-2024
- AQMS 11-14-2024
- Dividend Yield
- TENX N/A
- AQMS N/A
- EPS Growth
- TENX N/A
- AQMS N/A
- EPS
- TENX N/A
- AQMS N/A
- Revenue
- TENX N/A
- AQMS N/A
- Revenue This Year
- TENX N/A
- AQMS N/A
- Revenue Next Year
- TENX N/A
- AQMS N/A
- P/E Ratio
- TENX N/A
- AQMS N/A
- Revenue Growth
- TENX N/A
- AQMS 525.00
- 52 Week Low
- TENX $2.77
- AQMS $1.33
- 52 Week High
- TENX $21.46
- AQMS $14.14
- Technical
- Relative Strength Index (RSI)
- TENX 57.59
- AQMS 41.02
- Support Level
- TENX $5.92
- AQMS $1.92
- Resistance Level
- TENX $6.65
- AQMS $2.14
- Average True Range (ATR)
- TENX 0.43
- AQMS 0.28
- MACD
- TENX -0.02
- AQMS -0.05
- Stochastic Oscillator
- TENX 56.21
- AQMS 6.32
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.